(PharmaNewsWire.Com, October 31, 2017 ) Hyperbaric oxygen therapy is a procedure that delivers oxygen under increased atmospheric pressure. It is a non-invasive technique that treat a wide variety of acute and chronic conditions. This therapy involves the utilization of pressure chambers and consists of pure oxygen (100%). These pressure chambers provide sufficient oxygen levels to the blood of a damaged tissue. The air pressure in this chamber is three times greater than normal air pressure. Under high pressure, oxygen dissolves into the blood and other body fluids such as lymph, plasma, and cerebrospinal fluids. These oxygen-enriched fluids are circulated to the affected areas. As more oxygen enters the damaged tissues, the body responds efficiently to support its healing process.
Covered in this report This report covers the present and future scenario of the global hyperbaric oxygen therapy devices market for the period 2015-2019. To calculate the market size, Publisher uses revenue generated from the application of hyperbaric oxygen therapy devices.
Publisher's report, Global Hyperbaric oxygen Therapy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hyperbaric oxygen therapy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions - Americas - APAC - EMEA
Key vendors - ETC Biomedical Systems - Fink Engineering - Gulf Coast Hyperbarics - Oxyheal - Perry Baromedical
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
